ETHZilla Corp — Director's Dealing 2020

Dec 17, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: 180 Life Sciences Corp. (ATNF)
CIK: 0001690080
Period of Report: 2020-12-14

Reporting Person: KRAUSS MARLENE (10% Owner)
Reporting Person: KBL IV SPONSOR LLC (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-17	Common Stock	S	12103	$2.49	Disposed	2006858	Indirect
2020-12-17	Common Stock	S	4403	$2.44	Disposed	2018961	Indirect
2020-12-16	Common Stock	J	334608	$0.00	Acquired	334608	Direct
2020-12-16	Common Stock	J	520312	$0.00	Disposed	2023364	Indirect
2020-12-15	Common Stock	S	17877	$2.40	Disposed	2543676	Indirect
2020-12-14	Common Stock	S	10000	$2.45	Disposed	2561553	Indirect

Footnotes

F1: The securities are held directly by KBL IV Sponsor LLC ("KBL Sponsor"). Dr. Marlene Krauss, the former Chief Executive Officer, and a former member of the Board of Directors, of the issuer, is the sole managing member of KBL Sponsor. Consequently, she may be deemed the beneficial owner of the securities of the issuer held by KBL Sponsor, and she has sole voting and dispositive control over such securities. Dr. Krauss disclaims beneficial ownership over any securities of the issuer owned by KBL Sponsor in which she does not have a pecuniary interest.

F2: KBL Sponsor made a pro rata distribution for no consideration of an aggregate of 520,312 shares of the common stock of the issuer to its members on December 16, 2020.

F3: Represents 334,608 shares of the issuer's common stock that were received by Dr. Krauss in a pro rata distribution made by KBL Sponsor to its members on December 16, 2020. In prior reports, Dr. Krauss reported indirect beneficial ownership of all of the shares of the issuer's common stock held by KBL Sponsor.